Clinical Trials
5 trialsNCT06083038 2026-05-06
Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib
HealthPartners Institute
Completed
NCT04300790 2025-07-29
METALLICA
MedSIR
Phase 2 Completed
NCT04473378 2025-01-10
Glucose Monitoring During Chemotherapy
Columbia University
Completed
NCT04330625 2022-11-08
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)
Duke University
Phase 1 Terminated
NCT05107388 2021-11-04
AAREN
Centre Hospitalier Universitaire de Besancon
Phase NA Unknown